190 related articles for article (PubMed ID: 16470169)
1. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
[TBL] [Abstract][Full Text] [Related]
2. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
Liu Z; Zhu J; Cao H; Ren H; Fang X
Int J Oncol; 2012 May; 40(5):1553-60. PubMed ID: 22293682
[TBL] [Abstract][Full Text] [Related]
3. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
4. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
5. [Expression of RhoC and ROCK-1 and their effects on MAPK and Akt proteins in prostate carcinoma].
Bu Q; Tang HM; Tan J; Hu X; Wang DW
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):202-6. PubMed ID: 21575520
[TBL] [Abstract][Full Text] [Related]
6. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
7. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
Huang GX; Wang Y; Su J; Zhou P; Li B; Yin LJ; Lu J
Cancer Lett; 2017 Dec; 410():1-11. PubMed ID: 28923399
[TBL] [Abstract][Full Text] [Related]
9. Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.
Bartolomé RA; Molina-Ortiz I; Samaniego R; Sánchez-Mateos P; Bustelo XR; Teixidó J
Cancer Res; 2006 Jan; 66(1):248-58. PubMed ID: 16397238
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.
Joglekar M; Elbezanti WO; Weitzman MD; Lehman HL; van Golen KL
J Cell Biochem; 2015 Jun; 116(6):923-33. PubMed ID: 25559359
[TBL] [Abstract][Full Text] [Related]
11. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
Boone B; Brochez L
Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
[TBL] [Abstract][Full Text] [Related]
12. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
Liao Z; Zhao J; Yang Y
Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
[TBL] [Abstract][Full Text] [Related]
14. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
15. FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.
Wang J; Li L; Liu S; Zhao Y; Wang L; Du G
Oncotarget; 2016 Dec; 7(51):84375-84387. PubMed ID: 27533251
[TBL] [Abstract][Full Text] [Related]
16. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
Gao H; Liu R; Sun X
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
[TBL] [Abstract][Full Text] [Related]
17. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
[TBL] [Abstract][Full Text] [Related]
18. Disentangling the role of PI3K/Akt, Rho GTPase and the actin cytoskeleton on dengue virus infection.
Cuartas-López AM; Hernández-Cuellar CE; Gallego-Gómez JC
Virus Res; 2018 Sep; 256():153-165. PubMed ID: 30130602
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of expression of RhoC with invasiveness of breast cancer cells in vitro].
Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):898-903. PubMed ID: 18478927
[TBL] [Abstract][Full Text] [Related]
20. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]